Retinoids for ovarian cancer prevention: laboratory data set the stage for thoughtful clinical trials

The role of the molecular tumor board: learnings from the ROME trial.

NPJ precision oncology·2026

Window-of-opportunity trials to screen effective agents and optimize dose in breast cancer prevention.

NPJ breast cancer·2025

INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line.

British journal of cancer·2023

The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Breast conservation following neoadjuvant therapy for breast cancer in the modern era: Are we losing the opportunity?

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2016